The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function

被引:41
|
作者
Kong, Y. [1 ]
Wang, Y-T [1 ]
Hu, Y. [1 ,2 ]
Han, W. [1 ]
Chang, Y-J [1 ]
Zhang, X-H [1 ]
Jiang, Z-F [2 ,3 ]
Huang, X-J [1 ,2 ]
机构
[1] Peking Univ, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Collaborat Innovat Ctr Hematol, Peoples Hosp,Inst Hematol, Beijing 100044, Peoples R China
[2] Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing 100044, Peoples R China
[3] Peking Univ, Sch Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100044, Peoples R China
基金
中国国家自然科学基金;
关键词
VERSUS-HOST-DISEASE; RISK; FAILURE; ASSOCIATION; RECOVERY; LEUKEMIA; REDUCE; NICHE;
D O I
10.1038/bmt.2015.229
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Poor graft function (PGF), including early and late PGF, is a serious complication following allotransplant. We recently reported that bone marrow microenvironment abnormalities may occur in cases of late PGF. Whether these abnormalities occur in early PGF remains unknown. To answer this question, we performed a nested case-control study comparing cellular elements of the bone marrow microenvironment in 10 subjects with early PGF, 30 subjects with late PGF and 40 subjects without PGF. Bone marrow endosteal cells, perivascular cells and endothelial cells were analyzed by flow cytometry and by hematoxylin-eosin and immunohistochemical staining in situ. Subjects with early and late PGF had similar abnormalities in these cell types compared with transplant recipients without PGF. However, none of the aforementioned elements of the bone marrow microenvironment were significantly different between early and late PGF patients. Our data suggest that similar abnormalities in the bone marrow microenvironment may occur in early and late PGF post allotransplant. Cellular approaches, such as the administration of mesenchymal stem cells, promise to be beneficial therapeutic strategies in patients with early or late PGF.
引用
收藏
页码:249 / 255
页数:7
相关论文
共 50 条
  • [31] Graft Immune Cell Composition Associates with Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with AML
    Impola, Ulla
    Larjo, Antti
    Salmenniemi, Urpu
    Putkonen, Mervi
    Itala-Remes, Maija
    Partanen, Jukka
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [32] Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
    Shahzad, Moazzam
    Siddiqui, Raheel S.
    Anwar, Iqra
    Chaudhary, Sibgha Gull
    Ali, Tayyaba
    Naseem, Masooma
    Ahmed, Tehniat F.
    Ahmed, Zahoor
    Khurana, Sharad
    Ahmed, Nausheen
    Balusu, Ramesh
    Singh, Anurag K.
    Hematti, Peiman
    Callander, Natalie S.
    Abhyankar, Sunil H.
    McGuirk, Joseph P.
    Mushtaq, Muhammad Umair
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (10): : 877.e1 - 877.e8
  • [33] Decision Analysis of Peripheral Blood versus Bone Marrow Hematopoietic Stem Cells for Allogeneic Hematopoietic Cell Transplantation
    Pidala, Joseph
    Anasetti, Claudio
    Kharfan-Dabaja, Mohamed A.
    Cutler, Corey
    Sheldon, Andy
    Djulbegovic, Benjamin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (11) : 1415 - 1421
  • [34] Obesity is correlated with poor outcome after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia
    Yu, Jian
    Lin, Shangnao
    Luo, Yi
    Shi, Jimin
    Tan, Yamin
    Lai, Xiaoyu
    Zhao, Yanmin
    Ye, Yishan
    Zhu, Yuanyuan
    Zheng, Weiyan
    Huang, He
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (08) : 889 - 896
  • [35] The Incidence, Outcomes, and Risk Factors of Secondary Poor Graft Function in Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Aplastic Anemia
    Lin, Fan
    Han, Tingting
    Zhang, Yuanyuan
    Cheng, Yifei
    Xu, Zhengli
    Mo, Xiaodong
    Wang, Fengrong
    Yan, Chenhua
    Sun, Yuqian
    Wang, Jingzhi
    Tang, Feifei
    Han, Wei
    Chen, Yuhong
    Wang, Yu
    Zhang, Xiaohui
    Liu, Kaiyan
    Huang, Xiaojun
    Xu, Lanping
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [36] Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantation
    Nakamura, Zev M.
    Deal, Allison M.
    Rosenstein, Donald L.
    Quillen, Laura J.
    Chien, Stephanie A.
    Wood, William A.
    Shea, Thomas C.
    Park, Eliza M.
    SUPPORTIVE CARE IN CANCER, 2021, 29 (04) : 2007 - 2014
  • [37] Functional mesenchymal stem cells remain present in bone marrow microenvironment of patients with leukemia post-allogeneic hematopoietic stem cell transplant
    Ding, Li
    Zhu, Heng
    Yang, Yang
    Wang, Zhi-Dong
    Zheng, Xiao-Li
    Yan, Hong-Min
    Dong, Lei
    Zhang, Hai-Hong
    Han, Dong-Mei
    Xue, Mei
    Liu, Jing
    Zhu, Ling
    Guo, Zi-Kuan
    Wang, Heng-Xiang
    LEUKEMIA & LYMPHOMA, 2014, 55 (07) : 1635 - 1644
  • [38] Bone Marrow Mesenchymal Stem Cells for Improving Hematopoietic Function: An In Vitro and In Vivo Model. Part 2: Effect on Bone Marrow Microenvironment
    Carrancio, Soraya
    Blanco, Belen
    Romo, Carlos
    Muntion, Sandra
    Lopez-Holgado, Natalia
    Blanco, Juan F.
    Brinon, Jesus G.
    San Miguel, Jesus F.
    Sanchez-Guijo, Fermin M.
    Consuelo del Canizo, M.
    PLOS ONE, 2011, 6 (10):
  • [39] Comparison of Steady-State Bone Marrow and GCSF-Primed Stem Cell Sources Used in Allogeneic Hematopoietic Stem Cell Transplantation
    Nadeem, Hafiz Muhammad
    Ali, Asghar
    Shahbaz, Nighat
    Ghafoor, Tariq
    Khattak, Tariq Azam
    Chaudary, Qamar Un Nisa
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2024, 34 (03): : 355 - 359
  • [40] Second allogeneic hematopoietic stem cell transplantation: a treatment for graft failure
    Remberger, Mats
    Mattsson, Jonas
    Olsson, Richard
    Ringden, Olle
    CLINICAL TRANSPLANTATION, 2011, 25 (01) : E68 - E76